CG Oncology, Inc. Common stock

CGON· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$69.15-2.87%

2026-08-03

Financials

Valuation Metrics

CG Oncology, Inc. Common stock's Market Cap is $6.10B. At end of 2025 it was $3.21B. Ranked #1245 of 3,112 in US market (top 40%), #410 of 1,445 on NASDAQ (top 28%), #68 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 25%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$6.10B	US#1,245/3,112 Sec#68/269
Revenue	$5M	US#2,939/3,112 Sec#189/269
Net Income	$-187M	US—/3,112 Sec—/269
Total Assets	$1.14B	US#2,397/3,112 Sec#91/269
Net Assets	$1.09B	US#1,721/3,112 Sec#59/269
Value
P/B	5.59x	US#2,261/3,112 Sec#150/269
P/S	1509.70x	US#2,954/3,112 Sec#200/269
FCF Yield	-2.63%	US—/3,112 Sec—/269
Profitability
ROE	-17.10%	US#2,491/3,112 Sec#97/269
ROA	-16.45%	US#2,738/3,112 Sec#116/269
Op. Margin	-4238.99%	US#2,946/3,112 Sec#188/269
Revenue Growth	1982.69%	US#18/3,112 Sec#8/269
Financial Health
Debt Ratio	3.98%	US#36/3,112 Sec#11/269
Total Debt	$8M	US#2,811/3,112 Sec#208/269
FCF	$-160M	US#2,690/3,112 Sec#195/269
Cash	$34M	US#2,731/3,112 Sec#248/269
Current Ratio	31.30x	US#79/3,112 Sec#8/269
Performance
1Y Return	162.83%	US#141/3,112 Sec#47/269
1M Return	-1.72%	US#1,877/3,112 Sec#95/269
From 52W High	-10.19%	US#1,064/3,112 Sec#54/269
1Y MDD	-27.41%	US#1,181/3,112 Sec#69/269
Trading
Volume	608,733 shares	US#1,916/3,112 Sec#188/269
Trading Value	$42M	US#1,476/3,112 Sec#95/269
Per Share
EPS	$-2.08	US—/3,112 Sec—/269
BPS	$9.74	US#1,806/3,112 Sec#64/269